key: cord-0688499-s59xxifq
authors: Sechi, A.; Bassi, A.; Mazzatenta, C.; Cutrone, M.; Naldi, L.; Argenziano, G.; Piccolo, V.
title: Covid‐19 and Covid‐19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema
date: 2022-03-28
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.18093
sha: a97de3692d203bd1de7959d7eb0fbf087eda6429
doc_id: 688499
cord_uid: s59xxifq

nan

We herein report two cases of unilateral peripheral rash occurring in a paediatric patient and a young adult, respectively, during SARS-CoV-2 infection and after Covid-vaccine administration.

Case 1: a healthy 24-year-old woman presented an unilateral maculopapular eruption arising from her left groin, spreading up the side to involve the trunk and the left armpit, and to a lesser extent, contralateral groin (Fig. 1) . The rash was moderately itchy and consisted of discrete 1-4 mm-sized macules and papules with a tendency to coalescence in patchy erythema. Acral sites and mucous membranes were spared. The patient's past history was unremarkable, but she had received the second dose of Comirnaty â in the 48 h preceding the onset of the rash. Notably, the patient had never contracted the Sars-Cov2 infection, and her serological tests and swab test performed shortly before the first dose were negative. No other triggers could be identified, as the patient did neither complain of any systemic symptoms nor had taken any drugs or applied any products in the preceding three weeks. Laboratory screenings for blood count, autoimmunity, renal and hepatic functions were within normal ranges, whereas a mild raise of C-reactive protein was found (5.2 mg/dL). The patient was dismissed with the prescription of topical mometasone 1%, and the rash eventually resolved 3 weeks after. Case 2: a 1-year-old female child, isolated with her family due to a positive nasopharyngeal swab for Sars-Cov2, sought our teleconsultation for a unilateral maculopapular rash that appeared a couple of days before. Cutaneous lesions were asymptomatic and exclusively affected the right side of the body, mostly at the trunk and limbs (Fig. 2) . Systemic symptoms were mild and included flu-like symptoms, namely cough and cold. Currently, the rash is still present after 10 days, but is progressively fading with time. Since the advent of the pandemic, multiple skin manifestations have been reported in association with SARS-CoV-2 infection 1 or as immune-mediated events triggered by the administration of Covid-vaccines. 2,3 However, only a few reports of predominant unilateral rash have been linked to Covid-19. These include a case of asymmetrical periflexural rash arising with a marked predominance of the right side in a 42year-old woman affected by Covid-19, 4 and a purpuric rash involving unilaterally the left inguinal region of a 58-year-old man, hospitalized for Covid-19, which mainly ran asymptomatic, but caused ground glass pulmonary changes on the CTscan. 5 Unilaterality was also reported as a distinctive feature in one case of leukocytoclastic vasculitis of the lower limbs, which occurred 4 days after the second dose of COVAXIN â administered to a 31-year-old woman, unaffected by previous medical conditions. 6 Few exanthems are characterized by a distinct oneside predominance, including asymmetric periflexural exanthem of childhood (APEC), unilateral laterothoracic exanthem, and its variant known as unilateral mediothoracic exanthem. 6 The terms often design the same affection, although APEC is extremely rare in adults, being predominant among 1-to 5-year- Figure 1 Mildly itchy macules and papules spread along the left lateral thoracic wall and, in a less predominant fashion, the contralateral groin. old children; also it recognizes a viral aetiology in most cases, and usually peaks in the winter and springtime. 7 The reason for the unilateral predilection is still unexplained, although a postzygotic mutation that makes one-sided keratinocytes more susceptible to infectious triggers has been postulated. 8 It is possible that in our cases the keratinocytes of one side show, for the same reason, different reactogenicity to potential triggers. The production of the spike protein is a key element to elicit immunedriven skin reactions, mainly because it shares genetic analogies to human endogenous cross-reactive antigens. 9 As a consequence, both Sars-CoV-2 infection and Covid-vaccine, which are based on spike protein sequences, could trigger similar effects in genetically predisposed individuals. Besides molecular mimicry, other mechanisms may be implied, including T-cell mediate immune reactions, superantigen spreading, generation of autoreactive lymphocytes and cross-reactive antibodies with consequent release of pro-inflammatory cytokines. 3, 10 

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients

Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine

BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2

Unilateral laterothoracic exanthem in association with coronavirus disease 2019

A unilateral purpuric rash in a patient with COVID-19 infection

Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance

Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection

Unilateral mediothoracic exanthem: a variant of unilateral laterothoracic exanthem

Molecular mimicry between sars-cov-2 spike glycoprotein and mammalian proteomes: implications for the vaccine

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects

Patients in this manuscript have given written informed consent to the publication of their case details. 

None declared.

Data sharing is not applicable to this article as no new data were created or analysed in this study.